CD30-directed Antibody Interactions
- Name
- CD30-directed Antibody Interactions
- Accession Number
- DBCAT004453
- Description
Not Available
- Drugs
Drug Drug Description Brentuximab vedotin A CD30-directed antibody-drug conjugate used to treat various types of lymphoma. - Drugs & Drug Targets